PALMOPLANTAR PUSTULOSIS
Clinical trials for PALMOPLANTAR PUSTULOSIS explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug for painful hand and foot pustules fails to recruit enough patients
Disease control TerminatedThis study aimed to see if deucravacitinib, a pill taken daily, could reduce pustules and improve quality of life in people with moderate-to-severe palmoplantar pustulosis (PPP). Only 3 people enrolled before the trial was stopped early. The drug works by calming the immune syste…
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
New hope for rare skin condition: Long-Term drug safety trial launches
Disease control TerminatedThis study looks at the long-term safety of spesolimab in people with palmoplantar pustulosis, a painful skin condition causing blisters on hands and feet. Participants who saw improvement in earlier spesolimab trials can join and receive monthly injections for up to 5 years. Doc…
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Promising drug trial for hand and foot blisters halted early
Disease control TerminatedThis study tested a daily pill called deucravacitinib for people with palmoplantar pustulosis, a chronic skin condition causing painful blisters on the palms and soles. Only 3 adults with moderate-to-severe disease were enrolled before the trial was stopped early. The goal was to…
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 20, 2026 11:53 UTC